The Bio Protocol ecosystem welcomes a new wave of BioDAO projects and launchpad upgrades, promoting the expansion of the DeSci ecosystem

On January 6th, Bio Protocol officially announced the launch of its latest wave of BioDAO projects in January 2025, including Quantum Biology DAO, Long Covid Labs, and Curetopia. These projects focus on key challenges in cutting-edge scientific fields and aim to accelerate breakthrough progress using decentralized scientific research power (DeSci).

Quantum Biology DAO: Dedicated to developing quantum microscopes to advance biological research, founded by Dr. Clarice D. Aiello, a quantum biology expert at the Massachusetts Institute of Technology (MIT), has successfully raised over $6.80 million in funding through the launch board, and TGE (Token Generation Event) is about to go live.

Long Covid Labs: Initiated by Rohan Dixit, a former neuroscientist at Stanford University, the goal is to provide treatment options for COVID-19 patients who have been around for 100 million years. The first round of treatment plans has been released.

Curetopia: Family and patient community support for more than 10,000 rare diseases, initiated by Harvard Ph.D. Ethan Perlstein, who led a rare disease drug into Phase III clinical trials.

 

At the same time, Bio Protocol has launched a newly designed BioDAO Launchpad, empowering more roles and rights for $BIO holders:

Holders can support new projects and qualify for allowlist by pledging $BIO.

Holders can participate in the liquidity management of BioDAO and receive rewards through the milestone Incentive Mechanism.

The new launch board design makes the governance of each BioDAO more decentralized, driving more innovative projects into the ecosystem.

From the newly designed flowchart, it can be seen that the entire process of the launch board from project screening to liquidity support has been optimized, laying a stronger foundation for the long-term development of the Bio Protocol ecosystem. These improvements not only bring higher participation to holders, but also attract more decentralized scientific projects to settle in Bio Protocol.

 

With the launch of this series of innovations, Bio Protocol continues to lead the DeSci field, providing new perspectives and opportunities for scientific research and community empowerment. This is just the beginning, and there will be more projects worth looking forward to in the future!